Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Reconyl for Cough With/Without Sore Throat
NCT06510257Phase 2Completed
- Sponsor
- Dexa Medica
- Start
- Jul 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Reconyl in cough and pharyngitis (2 arms), sponsored by Dexa Medica. Primary endpoints: Cough score at Day 3, Visual Analogue Scale at Day 3 and 1 more. Started Jul 2024; status: completed.
02
Drugs
Reconyl
03
Conditions
coughpharyngitis
Beyond the preview
Go deeper on NCT06510257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06510257.